Associate Professor, Medicine, UCLA School of Medicine
Pulmonology
Dr. John A. Belperio, MD
|
|
Give Review
John A. Belperio, MD practices Pulmonology. He graduated from Temple University School of Medicine. He over the years received 3 awards: "Regional Top Doctor", "CMS Meaningful Use Stage 1 Certification" and "Super Doctor". Dr. John A. Belperio has written publications. He has 89 publications published with PubMed. The lastest publication is: 'The Role of TGF-β in the Association Between Primary Graft Dysfunction and Bronchiolitis Obliterans Syndrome.' He accepts Medicare.
Publications
- The Role of TGF-β in the Association Between Primary Graft Dysfunction and Bronchiolitis Obliterans Syndrome.
- CXCL9 Regulates TGF-β1-Induced Epithelial to Mesenchymal Transition in Human Alveolar Epithelial Cells.
- Staphylococcus via an Interaction With the ELR+ CXC Chemokine ENA-78 Is Associated With BOS.
- Neutrophil Extracellular Traps Are Pathogenic in Primary Graft Dysfunction After Lung Transplantation.
- Sarcoidosis-associated Pulmonary hypertension and lung transplantation for sarcoidosis.
- Interstitial Lung Disease in Patients with HepatoPulmonary Syndrome: A Case Series and New Observations.
- Changes in right heart haemodynamics and echocardiographic function in an advanced phenotype of Pulmonary hypertension and right heart dysfunction associated with pulm...
- Pulmonary hypertension complicating connective tissue disease.
- Pulmonary Hypertension Complicating Interstitial Lung Disease and COPD.
- CXCR3 Ligands Are Associated with the Continuum of Diffuse Alveolar Damage to Chronic Lung Allograft Dysfunction.
- Lung transplantation.
- Bronchiolitis obliterans syndrome: the achilles' heel of lung transplantation.
- DNA viral infections complicating Lung transplantation.
- Colonization with small conidia Aspergillus species is associated with Bronchiolitis obliterans syndrome: a two-center validation study.
- Pathologic findings in Lung allografts with anti-HLA antibodies.
- Interaction Between Pseudomonas and CXC Chemokines Increases Risk of BOS and Death in Lung Transplantation.
- Brief Report: Effect of ambrisentan treatment on exercise-induced Pulmonary hypertension in systemic sclerosis: A prospective single-center, open-label pilot study.
- Obliterative (constrictive) Bronchiolitis.
- Neurofibromatosis-associated diffuse Lung disease: case report.
- Usefulness of immune monitoring in Lung transplantation using adenosine triphosphate production in activated lymphocytes.
- Type I immune response cytokine-chemokine cascade is associated with Pulmonary arterial hypertension.
- Respiratory viral infections in hematopoietic stem cell and solid organ transplant recipients.
- Innate immune activation potentiates alloimmune Lung disease independent of chemokine (C-X-C motif) receptor 3.
- Immunosuppressive and cytotoxic therapy: pharmacology, toxicities, and monitoring.
- Non-tuberculous mycobacterium infection after Lung transplantation is associated with increased mortality.
- Lung transplantation: infection, inflammation, and the microbiome.
- Exercise-induced Pulmonary hypertension associated with systemic sclerosis: four distinct entities.
- Recurrent Pulmonary capillary hemangiomatosis after bilateral lung transplantation.
- Evolving concepts and controversies in Lung transplantation.
- Chronic allograft rejection: epidemiology, diagnosis, pathogenesis, and treatment.
- Pulmonary arterial hypertension and lung transplantation.
- Protection against Bronchiolitis obliterans syndrome is associated with allograft CCR7+ CD45RA- T regulatory cells.
- Treprostinil to reverse Pulmonary hypertension associated with idiopathic Pulmonary fibrosis as a bridge to single-lung transplantation.
- Diagnosis and hemodynamic assessment of Pulmonary arterial hypertension.
- Type I IFNs mediate development of postinfluenza bacterial Pneumonia in mice.
- Serum albumin concentration and waiting list mortality in idiopathic Interstitial pneumonia.
- Chronic lung allograft rejection: mechanisms and therapy.
- Quantification of cytokeratin 5 mRNA expression in the circulation of healthy human subjects and after Lung transplantation.
- Chemokines and transplant vasculopathy.
- Bronchoalveolar immunologic profile of acute human Lung transplant allograft rejection.
- Validation of a method to screen for Pulmonary hypertension in advanced idiopathic Pulmonary fibrosis.
- High-resolution chest CT findings do not predict the presence of Pulmonary hypertension in advanced idiopathic Pulmonary fibrosis.
- Differentiation of human circulating fibrocytes as mediated by transforming growth factor-beta and peroxisome proliferator-activated receptor gamma.
- Keratinocyte growth factor improves repair in the injured tracheal epithelium.
- Circulating peripheral blood fibrocytes in human fibrotic interstitial Lung disease.
- IL-13 is pivotal in the fibro-obliterative process of Bronchiolitis obliterans syndrome.
- Inflammation and angiogenesis in fibrotic Lung disease.
- Overview of Lung transplantation and criteria for selection of candidates.
- The role of cytokines during the pathogenesis of ventilator-associated and ventilator-induced Lung injury.
- CXCR3+CD4+ T cells mediate innate immune function in the pathophysiology of liver ischemia/reperfusion injury.
- Circulating progenitor epithelial cells traffic via CXCR4/CXCL12 in response to airway injury.
- CXCR3/CXCR3 ligand biological axis impairs RENCA tumor growth by a mechanism of immunoangiostasis.
- CXCR2/CXCR2 ligand biology during Lung transplant ischemia-reperfusion injury.
- CXCR2/CXCR2 ligand biological axis impairs alveologenesis during dsRNA-induced Lung inflammation in mice.
- Inhibition of polymorphonuclear leukocyte-mediated graft damage synergizes with short-term costimulatory blockade to prevent cardiac allograft rejection.
- Epidermal growth factor and hypoxia-induced expression of CXC chemokine receptor 4 on non-small cell Lung cancer cells is regulated by the phosphatidylinositol 3-kinas...
- CXCR2 is critical for dsRNA-induced Lung injury: relevance to viral Lung infection.
- Role of CXCR2/CXCR2 ligands in vascular remodeling during Bronchiolitis obliterans syndrome.
- CXCL11 attenuates bleomycin-induced Pulmonary fibrosis via inhibition of vascular remodeling.
- Pulmonary fibrosis.
- Mechanisms and mediators of Pulmonary fibrosis.
- CXC chemokines: angiogenesis, immunoangiostasis, and metastases in Lung cancer.
- Increased bronchoalveolar lavage human beta-defensin type 2 in Bronchiolitis obliterans syndrome after lung transplantation.
- The role of the Th2 CC chemokine ligand CCL17 in Pulmonary fibrosis.
- Circulating fibrocytes traffic to the Lungs in response to CXCL12 and mediate fibrosis.
- CXC chemokines in angiogenesis of Cancer.
- The SDF-1/CXCL 12/CXCR4 biological axis in non-small cell Lung cancer metastases.
- The chemokine receptor, CXCR2, mediates the tumorigenic effects of ELR+ CXC chemokines.
- CXCR2 is critical to hyperoxia-induced Lung injury.
- Depletion of CXCR2 inhibits tumor growth and angiogenesis in a murine model of Lung cancer.
- Role of CXCL9/CXCR3 chemokine biology during pathogenesis of acute Lung allograft rejection.
- Bronchiolitis obliterans syndrome complicating lung or heart-lung transplantation.
- Paying a toll for acute Lung allograft rejection.
- CXC chemokines in vascular remodeling related to Pulmonary fibrosis.
- The stromal derived factor-1/CXCL12-CXC chemokine receptor 4 biological axis in non-small cell Lung cancer metastases.
- Host innate defenses in the Lung: the role of cytokines.
- Elevated serum levels of the CXCR3 chemokine ITAC are associated with the development of transplant coronary artery Disease.
- Measurement of chemokines at the protein level in tissue.
- Critical role for CXCR2 and CXCR2 ligands during the pathogenesis of ventilator-induced Lung injury.
- Imbalance in the expression of CXC chemokines correlates with bronchoalveolar lavage fluid angiogenic activity and procollagen levels in acute Respiratory distress syn...
- CXC chemokines in angiogenesis related to Pulmonary fibrosis.
- Interaction of IL-13 and C10 in the pathogenesis of bleomycin-induced Pulmonary fibrosis.
- Critical role for CXCR3 chemokine biology in the pathogenesis of Bronchiolitis obliterans syndrome.
- Cytokines in innate host defense in the Lung.
- Interleukin-1 receptor antagonist as a biomarker for Bronchiolitis obliterans syndrome in lung transplant recipients.
- Use of Immunodeficient Mice for the Evaluation of CXC Chemokines in the Regulation of Tumor-associated Angiogenesis.
- Subsequent infections in survivors of sepsis: epidemiology and outcomes.
- Preoperative cardiac variables of diastolic dysfunction and clinical outcomes in Lung transplant recipients.
Schools
Temple University
University Of MD Med Sys
University Of Mi Hosps and Health Ctrs
Procedures Preformed
- Bronchoscopy
- Thoracentesis
- Ventilation Management
Conditions Treated
- Acidosis
- Asthma
- Atelectasis
- Bronchiectasis
- View All
Doctors Specialties
- Critical Care Medicine
- Pulmonology
Accepted Insurances
Awards
- Regional Top Doctor
- CMS Meaningful Use Stage 1 Certification
- Super Doctor
Education
-
University of Michigan Hospitals and Health Centers -
University of Maryland -
Temple University School of Medicine
Hospital
-
Ronald Reagan UCLA Medical Center -
Santa Monica-UCLA Medical Center and Orthopaedic Hospital
Drug Facts
| NPI NUMBER | 1285659482 | |
| NPPES Provider LastName | BELPERIO | |
| NPPES Provider FirstName | JOHN | |
| NPPES Provider ZIPCode | 900953075 | |
| NPPES Provider State | CA | |
| Specialty Description | Pulmonary Disease | |
| Total Claim Count | 1706.0 | |
| Distinct Opioid Count | 1.0 | |
| Opioid Claim Count | 11.0 | |
| Percent Opioid Claims | 0.64 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1285659482 |
| Last Name Of The Provider | BELPERIO |
| First Name Of The Provider | JOHN |
| View All |
Similar Doctors
|
Dr. Sterling L. Malish, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. John R. Chalison, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Joseph P. Lynch III, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Jaime Betancourt, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Gerald H. Markovitz, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Ahmet Baydur, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Gopal K. Batra, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Alex A. Balekian, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Michael D. Roth, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Amarish D. Pradhan, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Catherine C. Hooper, MD |
|
|
Dr. Ritbune Prakobkit, MD |
|
|
Dr. Yashaswini Yeragunta, MD |